Advanced colorectal cancer in young, HIV positive woman. Case report

Gineco eu ◽  
2017 ◽  
Vol 13 (4) ◽  
pp. 145-147
Author(s):  
Chirila S.
Oral Surgery ◽  
2021 ◽  
Author(s):  
Marta Aparecida Alberton Nuernberg ◽  
Gabriela Lopes‐Santos ◽  
Cristiane Furuse ◽  
Victor Ângelo Martins Montalli ◽  
Leticia Helena Theodoro ◽  
...  

2007 ◽  
Vol 19 (3) ◽  
pp. 343-346 ◽  
Author(s):  
M. Berretta ◽  
F. Martellotta ◽  
C. Simonelli ◽  
F. Di Benedetto ◽  
N. De Ruvo ◽  
...  

2010 ◽  
Vol 22 (2) ◽  
Author(s):  
JJ Kumwenda ◽  
M Nyirenda ◽  
T Tomoka ◽  
D Ricken ◽  
K Chalulu ◽  
...  

2016 ◽  
Vol 8 ◽  
pp. 18-20 ◽  
Author(s):  
Rikkert R. Ossendorp ◽  
Rob Silvis ◽  
Gerben J. van der Bij

2015 ◽  
Vol 68 (2) ◽  
pp. 103-108
Author(s):  
Momoko Kogo ◽  
Shintaro Nakajima ◽  
Yoshiko Uno ◽  
Mitsumasa Takeda ◽  
Kenta Tomori ◽  
...  

2015 ◽  
Vol 8 (3) ◽  
pp. 423-425 ◽  
Author(s):  
Corey A. Carter ◽  
Scott Z. Caroen ◽  
Arnold L. Oronsky ◽  
Bryan T. Oronsky

Inhibition of vascular endothelial growth factor (VEGF) signaling, an initiator of tumor angiogenesis, inhibits tumor growth and invasion. Bevacizumab, a monoclonal antibody to VEGF, in common use as an adjunct to standard chemotherapy like irinotecan in advanced colorectal cancer, also affects the normal (nontumor) vasculature. Dysphonia or voice changes have been anecdotally reported in patients that have been exposed to antiangiogenics. In this case report, we present an occurrence of severe dysphonia in a 60-year-old male with metastatic colorectal cancer after reintroduction of irinotecan and bevacizumab. To our knowledge, this is the first case of dysphonia associated with bevacizumab rechallenge.


2019 ◽  
Vol 7 (12) ◽  
pp. 2379-2383 ◽  
Author(s):  
Oronzo Brunetti ◽  
Angela Calabrese ◽  
Loredana Palermo ◽  
Antonio Giovanni Solimando ◽  
Antonella Argentiero

2021 ◽  
Vol 0 (0) ◽  
pp. 0-0
Author(s):  
Michael S. Krasovitsky ◽  
David Goldstein

2018 ◽  
Vol 93 (1) ◽  
pp. 128-130
Author(s):  
Takehiro Yoshii ◽  
Masanori Takahashi ◽  
Kei Funada ◽  
Taira Sato ◽  
Iichiro Ohtsu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document